Regulatory Challenges in Pharmaceutical Industry: An Economic Analysis

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

Ghasemi Mojtaba

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: IRANIAN JOURNAL OF BIOMEDICAL LAW AND ETHICS Year:2019 | Volume:1 | Issue:1 Page(s): 60-71

Download Full-Text

Persian Verion

View:

1,059

Download:

Cites:

Information Journal Paper

Title

Regulatory Challenges in Pharmaceutical Industry: An Economic Analysis

Author(s)

Ghasemi Mojtaba | Issue Writer Certificate

Keywords

Monopoly

Pharmaceutical industry

Pharmaceutical innovation

Regulation

Abstract

Background: The importance of Pharmaceutical industry in improving the quality of human life and the specific features of the cost structure of pharmaceutical agencies mandates proper Regulation in this industry. However, the complexity of this process has made the Regulation of this industry multifaceted, complex, and sometimes difficult for policymakers. This research seeks to illustrate the typical challenges and the behavioral patterns of various countries facing such issues. Methods: This research is based on the study of regulatory models in different countries. Results: The high cost of research and development of new drugs has culminated in perceiving the inescapable necessity to provide the legal context for supporting drug innovations, so that in the absence of these contexts to create a temporary Monopoly in the market for a new drug agency, there will be no incentive to invest in research and development of new drugs. But the creation of Monopoly will be accompanied by imposing prices higher than competitive prices with increasing dead loss and reduced social welfare. In such condition, the policy maker regulates the prices for reducing the pharmaceutical costs in both private and public sector in order to decrease the dead loss and control the legal market power of innovative pharmaceutical agencies. Conclusion: The Regulation in Pharmaceutical industry can be regarded as the art of establishing a balance and trade-off between these forces. American policy makers in this field have held innovation in high regards in comparison to their European, Canadian and Japanese counterparts, which has led the country to be the vanguard in Pharmaceutical innovation.

Cites

No record.

References

No record.

Cite

APA: Copy

Ghasemi, Mojtaba. (2019). Regulatory Challenges in Pharmaceutical Industry: An Economic Analysis. IRANIAN JOURNAL OF BIOMEDICAL LAW AND ETHICS, 1(1 ), 60-71. SID. https://sid.ir/paper/269038/en

Vancouver: Copy

Ghasemi Mojtaba. Regulatory Challenges in Pharmaceutical Industry: An Economic Analysis. IRANIAN JOURNAL OF BIOMEDICAL LAW AND ETHICS[Internet]. 2019;1(1 ):60-71. Available from: https://sid.ir/paper/269038/en

IEEE: Copy

Mojtaba Ghasemi, “Regulatory Challenges in Pharmaceutical Industry: An Economic Analysis,” IRANIAN JOURNAL OF BIOMEDICAL LAW AND ETHICS, vol. 1, no. 1 , pp. 60–71, 2019, [Online]. Available: https://sid.ir/paper/269038/en

Related Journal Papers